Screener
Immucell ICCC Q4 2025 Annual earnings
Reported March 4, 2026 · After market close
Revenue$7.6MBeat by $2.2M
EPS-$0.31Miss by $0.36
Revenue estimate$5.4M
EPS estimate$0.05
Next report
Date not yet announcedVersus estimates
Revenue
Q3 2026$8.0MBeat by $2.6MQ2 2026$7.2MBeat by $1.8MQ1 2026$10.4MBeat by $5.0M
Q4 2025$7.6MBeat by $2.2M
Q3 2025$5.5MQ2 2025$6.4MDiluted EPS
Q3 2026$0.10Beat by $0.05Q2 2026$0.20Beat by $0.15Q1 2026$0.21Beat by $0.16
Q4 2025-$0.31Miss by $0.36
Q3 2025-$0.02Q2 2025$0.06FAQ
- When did Immucell report Q4 2025 earnings?
- Immucell (ICCC) reported Q4 2025 earnings on March 4, 2026 after market close.
- What were Immucell's Q4 2025 revenue and EPS?
- Immucell reported revenue of $7.6M and eps of $-0.31 for Q4 2025.
- Did Immucell beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $5.4M by $2.2M. EPS missed the consensus estimate of $0.05 by $0.36.
- How did Immucell's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 1.6% from $7.8M a year earlier.
- Where can I find Immucell's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001437749-26-006912) and the 10-K periodic report (0001437749-26-010339) directly on SEC EDGAR. The filing index links above go to sec.gov.
